Technical Data
034012
CLPTM1L, CT (CLPTM1L, CRR9, Cleft lip and palate transmembrane protein 1-like protein, Cisplatin resistance-related protein 9)
Description:
CLPTM1L enhances cisplatin-mediated apoptosis, when overexpressed.

Applications:
Suitable for use in Western Blot, ELISA

Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:100-500

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
200ul-20CBlue IceHumanRabbit
Concentration:
As reported
Immunogen:
CLPTM1L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 369-399 amino acids from the C-terminal region of human CLPTM1L.
Purity:
Purified by Protein A affinity chromatography.
Form
Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.
Specificity:
Human
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
Liu, Z., et al. Carcinogenesis 31(11):1977-1981(2010) Hsiung, C.A., et al. PLoS Genet. 6 (8) (2010) : Truong, T., et al. J. Natl. Cancer Inst. 102(13):959-971(2010) Pooley, K.A., et al. Cancer Epidemiol. Biomarkers Prev. 19(7):1862-1865(2010) Turnbull, C., et al. Nat. Genet. 42(7):604-607(2010)